Contralateral prophylactic mastectomy: What do we know and what do our patients know?

Journal of Clinical Oncology

Volumn 29, Issue 16, 2011, Pages 2132-2135

  Khan, Seema A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; TAMOXIFEN;

BREAST BIOPSY; BREAST CANCER; BREAST RECONSTRUCTION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CLINICAL DECISION MAKING; CONTRALATERAL PROPHYLACTIC MASTECTOMY; EDITORIAL; GENE MUTATION; HUMAN; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SATISFACTION; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION EXPOSURE;

BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MASTECTOMY;

EID: 79957949654     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.33.4482     Document Type: Editorial

References (16)

1. Stucky CC, Gray RJ, Wasif N, et al: Increase in contralateral prophylactic mastectomy: Echoes of a bygone era? Surgical trends for unilateral breast cancer. Ann Surg Oncol 17:330-337, 2010
2. Arrington AK, Jarosek SL, Virnig BA, et al: Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol 16:2697-2704, 2009
3. Bedrosian I, Hu CY, Chang GJ: Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst 102:401-409, 2010
4. Jones NB, Wilson J, Kotur L, et al: Contralateral prophylactic mastectomy for unilateral breast cancer: An increasing trend at a single institution. Ann Surg Oncol 16:2691-2696, 2009
5. Sorbero ME, Dick AW, Beckjord EB, et al: Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol 16:1597-1605, 2009
6. Cuzick J, Sestak I, Baum M, et al: Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11:1135-1141, 2010
7. Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
8. King TA, Sakr R, Patil S, et al: Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 29:2158-2164, 2011
9. Boughey JC, Hoskin TL, Degnim AC, et al: Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer. Ann Surg Oncol 17:2702-2709, 2010
10. Kurian AW, McClure LA, John EM, et al: Second primary breast cancer occurrence according to hormone receptor status. J Natl Cancer Inst 101:1058-1065, 2009
11. Bouchardy C, Benhamou S, Fioretta G, et al: Risk of second breast cancer according to estrogen receptor status and family history. Breast Cancer Res Treat [epub ahead of print on September 29, 2010]
12. Lostumbo L, Carbine NE, Wallace J: Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 11:CD002748, 2010
13. Frost MH, Schaid DJ, Sellers TA, et al: Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284:319-324, 2000 (Pubitemid 30469858)
14. Zion SM, Slezak JM, Sellers TA, et al: Reoperations after prophylactic mastectomy with or without implant reconstruction. Cancer 98:2152-2160, 2003 (Pubitemid 37392418)
15. Gahm J, Wickman M, Brandberg Y: Bilateral prophylactic mastectomy in women with inherited risk of breast cancer - Prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery. Breast 19:462-469, 2010
16. Gärtner R, Jensen MB, Nielsen J, et al: Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 302:1985-1992, 2009